The present invention provides an anticancer composition containing lipoteichoic acid, TNF-α, and IFN-γ as active components. According to the present invention, the anticancer composition has fewer side effects than existing anticancer agents since lipoteichoic acid, TNF-α, and IFN-γ act on target cells, thereby specifically activating a signaling system associated with auto-apoptosis.COPYRIGHT KIPO 2020본 발명은 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 포함하는 항암용 조성물이 제공된다.